- Home
- FSP vs LYEL Comparison
FSP vs LYEL Comparison
Compare FSP & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSP
- LYEL
- Stock Information
- Founded
- FSP 1981
- LYEL 2018
- Country
- FSP United States
- LYEL United States
- Employees
- FSP N/A
- LYEL N/A
- Industry
- FSP Real Estate Investment Trusts
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- FSP Real Estate
- LYEL Health Care
- Exchange
- FSP Nasdaq
- LYEL Nasdaq
- Market Cap
- FSP 187.5M
- LYEL 203.9M
- IPO Year
- FSP N/A
- LYEL 2021
- Fundamental
- Price
- FSP $1.94
- LYEL $0.70
- Analyst Decision
- FSP
- LYEL Sell
- Analyst Count
- FSP 0
- LYEL 2
- Target Price
- FSP N/A
- LYEL $1.00
- AVG Volume (30 Days)
- FSP 200.2K
- LYEL 1.3M
- Earning Date
- FSP 02-11-2025
- LYEL 03-03-2025
- Dividend Yield
- FSP 2.05%
- LYEL N/A
- EPS Growth
- FSP N/A
- LYEL N/A
- EPS
- FSP N/A
- LYEL N/A
- Revenue
- FSP $120,112,000.00
- LYEL $63,000.00
- Revenue This Year
- FSP N/A
- LYEL N/A
- Revenue Next Year
- FSP $0.81
- LYEL N/A
- P/E Ratio
- FSP N/A
- LYEL N/A
- Revenue Growth
- FSP N/A
- LYEL N/A
- 52 Week Low
- FSP $1.47
- LYEL $0.51
- 52 Week High
- FSP $2.47
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- FSP 54.37
- LYEL 64.48
- Support Level
- FSP $1.94
- LYEL $0.57
- Resistance Level
- FSP $2.07
- LYEL $0.63
- Average True Range (ATR)
- FSP 0.08
- LYEL 0.05
- MACD
- FSP 0.02
- LYEL 0.02
- Stochastic Oscillator
- FSP 55.88
- LYEL 87.86
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.